DexLeChem founder give advice to Berlin senate
Which are the best strategies to promote the German health industry? Jost and Rahmel, DexLeChem are invited to discuss this issue with Dr. T. Strüngmann, founder of Hexal and Dr. A. Ziegler, CEO Ziegler AG on November 18 on the panel.
Innovative approaches such as catalyst re-using developed by DexLeChem are an important contribution to cost-saving and more sustainability in pharmaceutical production. The event “innovation meets politics” has the objective of finding suitable strategies and developing new ideas to promote the health sector in Berlin and Germany. Gottfried Ludewig, spokesman on health policy of the Christian Democrates initiated the event.